pmc logo imageJournal ListSearchpmc logo image
Logo of vhriskmanJournal URL: redirect3.cgi?&&auth=0b10v46NfmrSN1EsuPyLkXFO0ESrf8Xl69IC_O5PF&reftype=publisher&issue-id=165139&journal-id=391&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=69
Other Issues:  previous | next | latest | archive
Volume 3(6);  December 2007
Editorial
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension
Vasc Health Risk Manag. 2007 December; 3(6): 783–795.
PMCID: PMC2350144
Reviews
A review of nateglinide in the management of patients with type 2 diabetes
Nicholas Tentolouris, Christina Voulgari, and Nicholas Katsilambros
Vasc Health Risk Manag. 2007 December; 3(6): 797–807.
PMCID: PMC2350129
Aliskiren – an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension
Kristina Allikmets
Vasc Health Risk Manag. 2007 December; 3(6): 809–815.
PMCID: PMC2350136
Obesity management: Update on orlistat
Belinda S Drew, Andrew F Dixon, and John B Dixon
Vasc Health Risk Manag. 2007 December; 3(6): 817–821.
PMCID: PMC2350121
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications
Brian C Cumbie and Kathie L Hermayer
Vasc Health Risk Manag. 2007 December; 3(6): 823–832.
PMCID: PMC2350125
Review of duloxetine in the management of diabetic peripheral neuropathic pain
Timothy Smith and Robert A Nicholson
Vasc Health Risk Manag. 2007 December; 3(6): 833–844.
PMCID: PMC2350145
Atherogenic lipid profiles and its management in patients with rheumatoid arthritis
Michael T Nurmohamed
Vasc Health Risk Manag. 2007 December; 3(6): 845–852.
PMCID: PMC2350142
Endothelial dysfunction in diabetes mellitus
Hadi AR Hadi and Jassim Al Suwaidi
Vasc Health Risk Manag. 2007 December; 3(6): 853–876.
PMCID: PMC2350146
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date
Antonio Gaddi, AFG Cicero, FO Odoo, A Poli A, R Paoletti, and On behalf of the Atherosclerosis and Metabolic Diseases Study Group
Vasc Health Risk Manag. 2007 December; 3(6): 877–886.
PMCID: PMC2350131
Review of bosentan in the management of pulmonary arterial hypertension
Eli Gabbay, John Fraser, and Keith McNeil
Vasc Health Risk Manag. 2007 December; 3(6): 887–900.
PMCID: PMC2350123
Clinical trial update: focus on the ONTARGET study
David Fitchett
Vasc Health Risk Manag. 2007 December; 3(6): 901–908.
PMCID: PMC2350133
A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
Cockcroft John
Vasc Health Risk Manag. 2007 December; 3(6): 909–917.
PMCID: PMC2350132
Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes
Nazia Raja-Khan, Sarah S Warehime, and Robert A Gabbay
Vasc Health Risk Manag. 2007 December; 3(6): 919–935.
PMCID: PMC2350128
Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature
Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, and Bobby V Khan
Vasc Health Risk Manag. 2007 December; 3(6): 937–945.
PMCID: PMC2350139
Inhaled insulin for controlling blood glucose in patients with diabetes
Bernard L Silverman, Christopher J Barnes, Barbara N Campaigne, and Douglas B Muchmore
Vasc Health Risk Manag. 2007 December; 3(6): 947–958.
PMCID: PMC2350138
The applicability of home blood pressure measurement in clinical practice: A review of literature
Willem J Verberk, Abraham A Kroon, Heidi A Jongen-Vancraybex, and Peter W de Leeuw
Vasc Health Risk Manag. 2007 December; 3(6): 959–966.
PMCID: PMC2350150
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
Molavi Behzad, Rassouli Negah, Bagwe Suveer, and Rasouli Neda
Vasc Health Risk Manag. 2007 December; 3(6): 967–973.
PMCID: PMC2350137
Reduction of C-reactive protein and the use of anti-hypertensives
Carmine Savoia and Ernesto L Schiffrin
Vasc Health Risk Manag. 2007 December; 3(6): 975–983.
PMCID: PMC2350124
Rationale for multiple risk intervention: The need to move from theory to practice
Leif R Erhardt
Vasc Health Risk Manag. 2007 December; 3(6): 985–997.
PMCID: PMC2350141
Original Research
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice
Maddalena Veronesi, Arrigo FG Cicero, Maria Grazia Prandin, Ada Dormi, Eugenio Cosentino, Enrico Strocchi, and Claudio Borghi
Vasc Health Risk Manag. 2007 December; 3(6): 999–1005.
PMCID: PMC2350135
Rheumatic heart disease: 15 years of clinical and immunological follow-up
Roney O Sampaio, Kellen C Fae, Lea MF Demarchi, Pablo MA Pomerantzeff, Vera D Aiello, Guilherme S Spina, Ana C Tanaka, Sandra E Oshiro, Max Grinberg, Jorge Kalil, and Luiza Guilherme
Vasc Health Risk Manag. 2007 December; 3(6): 1007–1017.
PMCID: PMC2350126
Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease
Mohammed Al-Omran
Vasc Health Risk Manag. 2007 December; 3(6): 1019–1027.
PMCID: PMC2350143
Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy
John M Flack, Karl Duncan, Suzanne E Ohmit, Ruth Quah, Xuefeng Liu, Preeti Ramappa, Sandra Norris, Lowell Hedquist, Amanda Dudley, and Samar A Nasser
Vasc Health Risk Manag. 2007 December; 3(6): 1029–1037.
PMCID: PMC2350134
Higher persistence with valsartan compared with enalapril in daily practice
Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, and Ron MC Herings
Vasc Health Risk Manag. 2007 December; 3(6): 1039–1044.
PMCID: PMC2350122
Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction
Lena Björck, Catharina Welin, and Annika Rosengren
Vasc Health Risk Manag. 2007 December; 3(6): 1045–1051.
PMCID: PMC2350148
Pathogenic role of cardiac mast cell activation/degranulation, TNF-α, and cell death in acute drug-related fatalities
Nasrin Perskvist, Carl Söderberg, Marianne van Hage, and Erik Edston
Vasc Health Risk Manag. 2007 December; 3(6): 1053–1062.
PMCID: PMC2350147
Adult nontwin sib concordance rates for type 2 diabetes, hypertension and metabolic syndrome among Asian Indians: The Indian Atherosclerosis Research Study
Jayashree Shanker, Saikat Kanjilal, Veena S Rao, Ganapathy Perumal, Natesha B Khadrinarasimhiah, Manjari Mukherjee, Shamanna S Iyengar, and Vijay V Kakkar
Vasc Health Risk Manag. 2007 December; 3(6): 1063–1068.
PMCID: PMC2350127
Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity
Barbara Ludolph, Wilhelm Bloch, Malte Kelm, Rainer Schulz, and Petra Kleinbongard
Vasc Health Risk Manag. 2007 December; 3(6): 1069–1073.
PMCID: PMC2350149
Acute management of poor condition subarachnoid hemorrhage patients
Archavlis Eleftherios and Mario Nazareno Carvi y Nievas
Vasc Health Risk Manag. 2007 December; 3(6): 1075–1082.
PMCID: PMC2350130
Case Report
Isolated periaortitis: Clinical and imaging characteristics
Abdel-Rauf Zeina, Slobodin Gleb, Jochanan E Naschitz, Zeev Loberman, and Elisha Barmeir
Vasc Health Risk Manag. 2007 December; 3(6): 1083–1086.
PMCID: PMC2350140
Other Issues:  previous | next | latest | archive